About Us
Asia Air WatchLive PM2.5 Medical Alerts
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Response-equivalent dosing of follitropin alfa and follitropin delta in Japanese women: a cross-fitted retrospective cohort study.

Researchers

Masato Kobanawa, Kenji Sato

Abstract

To develop a Japanese population-specific empirical conversion between follitropin alfa IU and follitropin delta &#xb5;g based on comparable ovarian response and to evaluate its response and clinical consistency. This retrospective single-center cohort included 231 first cycles with follitropin alfa and 154 with follitropin delta. Overlap weighting balanced age, body weight, antral follicle count, anti-M&#xfc;llerian hormone, basal FSH, and basal LH. Inverse response calibration incorporated oocyte yield, follicle-to-oocyte index (FOI), and follicular output rate (FORT). Five-fold cross-fitting assessed coefficient stability and held-out response equivalence. Follicular, endocrine, embryological, and reproductive outcomes were additionally compared at cross-fitted response-equivalent doses. The conversion was follitropin delta (&#xb5;g/day)&#x2009;=&#x2009;4.581&#x2009;+&#x2009;0.02244&#x2009;&#xd7;follitropin alfa (IU/day) (R<sup>2</sup>&#x2009;=&#x2009;0.704), corresponding to 7.95, 9.63, and 11.31&#x2005;&#xb5;g for 150, 225, and 300 IU. Fold-specific slopes ranged from 0.02144 to 0.02327&#x2005;&#xb5;g/IU. In held-out observations, FOI (difference -0.033; 90% CI, -0.097 to 0.031) and FORT (0.001; -0.097 to 0.100) met &#xb1;0.10 equivalence margins, whereas oocyte yield (-1.40; -2.65 to -0.15) did not meet the &#xb1;2-oocyte margin. Follicular, embryological, and cumulative reproductive outcomes were broadly consistent between preparations across response-equivalent dose levels. This Japanese population-specific conversion was stable across cross-fitting and supported response equivalence for FOI and FORT. Clinical outcome analyses further supported the consistency of the proposed response-equivalent dose relationship. https://jrct.mhlw.go.jp/en-latest-detail/jRCT1031260453, This observational study was registered in the Japan Registry of Clinical Trials jRCT1031260453.
Source: PubMed (PMID: 43065508)View Original on PubMed